The plant biotechnology flight: is Africa on board?
暂无分享,去创建一个
[1] J. Machuka. Agricultural biotechnology for Africa. African scientists and farmers must feed their own people. , 2001, Plant physiology.
[2] Thomas Kazen. Purification , 2004, Nature Biotechnology.
[3] R. Reski,et al. Glyco-engineering of moss lacking plant-specific sugar residues. , 2005, Plant biology.
[4] J. Ma,et al. Genetically modified plants and human health , 2008, Journal of the Royal Society of Medicine.
[5] J. L. Gould,et al. TIT FOR TAT , 1984 .
[6] M. Boojar,et al. Regular Paper , 2013 .
[7] J. Thomson. The role of biotechnology for agricultural sustainability in Africa , 2008, Philosophical Transactions of the Royal Society B: Biological Sciences.
[8] Monica A. Schmidt,et al. Production of Escherichia coli heat labile toxin (LT) B subunit in soybean seed and analysis of its immunogenicity as an oral vaccine. , 2007, Vaccine.
[9] O. Lau,et al. Plant seeds as bioreactors for recombinant protein production. , 2009, Biotechnology advances.
[10] O. Edelbaum,et al. Expression of Active Human Interferon-β in Transgenic Plants , 1992 .
[11] H. Borer. In name only , 2005 .
[12] Elias Mossialos,et al. ‘Ambivalent’ individual preferences towards biotechnology in the European Union: products or processes? , 2005 .
[13] S. Ayele,et al. Partnerships in African crop biotech , 2006, Nature Biotechnology.
[14] S. Korban,et al. Expression of an Escherichia coli antigenic fusion protein comprising the heat labile toxin B subunit and the heat stable toxin, and its assembly as a functional oligomer in transplastomic tobacco plants. , 2009, The Plant journal : for cell and molecular biology.
[15] Albert Sasson. Agricultural Biotechnology in Africa , 2004 .
[16] S. Streatfield,et al. Plant-based vaccines. , 2003, International journal for parasitology.
[17] P. Lerouge,et al. N-Glycosylation of a mouse IgG expressed in transgenic tobacco plants. , 1999, Glycobiology.
[18] C. Marusic,et al. Plant pharming of a full-sized, tumour-targeting antibody using different expression strategies. , 2009, Plant biotechnology journal.
[19] K. Cao,et al. Immunogenicity of recombinant hepatitis B virus surface antigen fused with preS1 epitopes expressed in rice seeds , 2008, Transgenic Research.
[20] A. Khandelwal,et al. Expression of hemagglutinin protein of Rinderpest virus in transgenic pigeon pea [Cajanus cajan (L.) Millsp.] plants , 2003, Plant Cell Reports.
[21] P. Elzen,et al. Production of Correctly Processed Human Serum Albumin in Transgenic Plants , 1990, Bio/Technology.
[22] P. Christou,et al. Cost-effective production of a vaginal protein microbicide to prevent HIV transmission , 2008, Proceedings of the National Academy of Sciences.
[23] H. Mason,et al. Oral immunization with a recombinant bacterial antigen produced in transgenic plants , 1995, Science.
[24] A. Steinmetz,et al. Neutralizing immunogenicity of transgenic carrot (Daucus carota L.)-derived measles virus hemagglutinin , 2003, Plant Molecular Biology.
[25] M. Aickin,et al. Researching complementary and alternative treatments – the gatekeepers are not at home , 2007, BMC Medical Research Methodology.
[26] C. Borroto,et al. An integral approach towards a practical application for a plant-made monoclonal antibody in vaccine purification. , 2005, Vaccine.
[27] R. Bennett,et al. Farm-Level Economic Performance of Genetically Modified Cotton in Maharashtra, India , 2006 .
[28] M. Theisen,et al. Triple helix assembly and processing of human collagen produced in transgenic tobacco plants , 2000, FEBS letters.
[29] P. Lerouge,et al. Transient co-expression for fast and high-yield production of antibodies with human-like N-glycans in plants. , 2009, Plant biotechnology journal.
[30] M. Levine,et al. Human immune responses to a novel norwalk virus vaccine delivered in transgenic potatoes. , 2000, The Journal of infectious diseases.
[31] P. Lerouge,et al. Galactose-extended glycans of antibodies produced by transgenic plants , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[32] Zhe-zhi Wang,et al. Expression of human papillomavirus type 16 L1 protein in transgenic tobacco plants. , 2005, Acta biochimica et biophysica Sinica.
[33] V. Konde. The Biotechnology Revolution and its Implications for Food Security in Africa , 2006 .
[34] D. M. Lam,et al. Expression of hepatitis B surface antigen in transgenic plants. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[35] Nicholas Ozor,et al. Challenges and impacts of agricultural biotechnology on developing societies , 2008 .
[36] J. Claverie. Recombinant Protein Expression , 2004 .
[37] N. Fairweather,et al. Protection against tetanus toxin using a plant‐based vaccine , 2005, European journal of immunology.
[38] H. Daniell,et al. Expression of an environmentally friendly synthetic protein-based polymer gene in transgenic tobacco plants , 1996, Plant Cell Reports.
[39] V. S. Reddy,et al. Chloroplast expression of His-tagged GUS-fusions: a general strategy to overproduce and purify foreign proteins using transplastomic plants as bioreactors , 2004, Molecular Breeding.
[40] Deborah P Delmer,et al. Agriculture in the developing world: Connecting innovations in plant research to downstream applications. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[41] Richard A Lerner,et al. Expression and assembly of a fully active antibody in algae , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[42] Gary P. Fitt,et al. Implementation and Impact of Transgenic Bt Cottons in Australia , 2004 .
[43] H. Daniell,et al. Field production and functional evaluation of chloroplast-derived interferon-alpha2b. , 2007, Plant biotechnology journal.
[44] R. Levy,et al. Plant-produced idiotype vaccines for the treatment of non-Hodgkin's lymphoma: Safety and immunogenicity in a phase I clinical study , 2008, Proceedings of the National Academy of Sciences.
[45] Y. Qi,et al. Assessment of the utility of the tomato fruit-specific E8 promoter for driving vaccine antigen expression , 2008, Genetica.
[46] M. Levine,et al. Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato , 1998, Nature Medicine.
[47] Robert L. Paarlberg,et al. Starved for Science: How Biotechnology Is Being Kept Out of Africa , 2008 .
[48] K. Musiychuk,et al. A plant-produced plague vaccine candidate confers protection to monkeys. , 2007, Vaccine.
[49] R. Visser,et al. Expression of an expansin carbohydrate-binding module affects xylem and phloem formation , 2007 .
[50] E. Aronson,et al. My enemy's enemy is my friend. , 1968, Journal of personality and social psychology.
[51] Julie A. Morris,et al. Expression of exogenous protein in the egg white of transgenic chickens , 2002, Nature Biotechnology.
[52] S. Marillonnet,et al. Protection conferred by recombinant Yersinia pestis antigens produced by a rapid and highly scalable plant expression system. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[53] Matin Qaim,et al. Bt Cotton in India: Field Trial Results and Economic Projections , 2003 .
[54] P. Verma,et al. Plants as bioreactors for the production of vaccine antigens , 2009, Biotechnology Advances.
[55] M. Gómez-Lim,et al. Expression of Functional Interleukin-12 from Mouse in Transgenic Tomato Plants , 2005, Transgenic Research.
[56] Jikun Huang,et al. 'Bt cotton' benefits, costs and impacts in China , 2003 .
[57] M. Gómez-Lim,et al. Transgenic tomato expressing interleukin‐12 has a therapeutic effect in a murine model of progressive pulmonary tuberculosis , 2008, Clinical and experimental immunology.
[58] G. Sheppard. NO-GO AREAS , 2002 .
[59] R. Reski,et al. The moss bioreactor. , 2004, Current opinion in plant biology.
[60] Mariam B. Sticklen,et al. Plant genetic engineering for biofuel production: towards affordable cellulosic ethanol , 2010, Nature Reviews Genetics.
[61] A. Hiatt,et al. Production of antibodies in transgenic plants , 1989, Nature.
[62] U. Sonnewald,et al. Molecular Farming in Plants , 2012 .
[63] H. Daniell,et al. Overexpression of the Bt cry2Aa2 operon in chloroplasts leads to formation of insecticidal crystals , 2001, Nature Biotechnology.
[64] M. Sharma,et al. Plants as bioreactors: Recent developments and emerging opportunities , 2009, Biotechnology Advances.
[65] Rainer Fischer,et al. Evolution of a regulatory framework for pharmaceuticals derived from genetically modified plants. , 2008, Trends in biotechnology.
[66] P. Christou,et al. A recombinant multimeric immunoglobulin expressed in rice shows assembly-dependent subcellular localization in endosperm cells. , 2004, Plant biotechnology journal.
[67] Amit Ghosh,et al. Expression of toxin co-regulated pilus subunit A (TCPA) of Vibrio cholerae and its immunogenic epitopes fused to cholera toxin B subunit in transgenic tomato (Solanum lycopersicum) , 2008, Plant Cell Reports.
[68] John A. Howard,et al. Commercial production of avidin from transgenic maize: characterization of transformant, production, processing, extraction and purification , 1997, Molecular Breeding.
[69] Jeffrey R. Lane,et al. Maize (Zea mays)‐derived bovine trypsin: characterization of the first large‐scale, commercial protein product from transgenic plants , 2003, Biotechnology and applied biochemistry.
[70] R. Bock,et al. Exhaustion of the chloroplast protein synthesis capacity by massive expression of a highly stable protein antibiotic. , 2009, The Plant journal : for cell and molecular biology.
[71] J. A. Carroll,et al. High-yield production of a human therapeutic protein in tobacco chloroplasts , 2000, Nature Biotechnology.
[72] Joel I. Cohen,et al. Poorer nations turn to publicly developed GM crops , 2005, Nature Biotechnology.
[73] L. Baillie,et al. Human-derived, plant-produced monoclonal antibody for the treatment of anthrax. , 2005, Vaccine.
[74] E. Rybicki,et al. Transient expression of Human papillomavirus type 16 L1 protein in Nicotiana benthamiana using an infectious tobamovirus vector. , 2006, Virus research.
[75] David Lee,et al. Genetically Engineered Crops for Biofuel Production: Regulatory Perspectives , 2008, Biotechnology & genetic engineering reviews.
[76] Rainer Fischer,et al. Opportunities for recombinant antigen and antibody expression in transgenic plants--technology assessment. , 2005, Vaccine.
[77] R. Fischer,et al. Optimization of human papillomavirus type 16 (HPV-16) L1 expression in plants: comparison of the suitability of different HPV-16 L1 gene variants and different cell-compartment localization. , 2007, The Journal of general virology.
[78] A. Daar,et al. The 20-year African biotech plan , 2008, Nature Biotechnology.
[79] O. Edelbaum,et al. Expression of active human interferon-beta in transgenic plants. , 1992, Journal of interferon research.
[80] J. Kaiser. Is the Drought Over for Pharming? , 2008, Science.
[81] R. Bennett,et al. Bt-cotton boosts the gross margin of small-scale cotton producers in South Africa , 2005 .
[82] Jie Yu,et al. A plant-based multicomponent vaccine protects mice from enteric diseases , 2001, Nature Biotechnology.
[83] Yuanlei Hu,et al. Expression and characteristic of synthetic human epidermal growth factor (hEGF) in transgenic tobacco plants , 2007, Biotechnology Letters.
[84] E. Rybicki,et al. Maize streak virus-resistant transgenic maize: a first for Africa. , 2007, Plant biotechnology journal.
[85] Carola Engler,et al. Rapid high-yield expression of full-size IgG antibodies in plants coinfected with noncompeting viral vectors , 2006, Proceedings of the National Academy of Sciences.
[86] F. Wambugu. Why Africa needs agricultural biotech , 1999, Nature.
[87] G. Sinha. GM Technology Develops in the Developing World , 2007, Science.
[88] C. Hung,et al. Overexpression of human erythropoietin in tobacco does not affect plant fertility or morphology , 2009, Plant Biotechnology Reports.
[89] C. Nykiforuk,et al. Transgenic expression and recovery of biologically active recombinant human insulin from Arabidopsis thaliana seeds. , 2006, Plant biotechnology journal.
[90] K. Rietveld,et al. Direct screening for high-level expression of an introduced α-amylase gene in plants , 1992, Plant Molecular Biology.
[91] H. Kiyono,et al. Rice-based mucosal vaccine as a global strategy for cold-chain- and needle-free vaccination , 2007, Proceedings of the National Academy of Sciences.
[92] T. Lehner,et al. Generation and assembly of secretory antibodies in plants , 1995, Science.
[93] M. Rodriguez-Franco,et al. High‐level expression of secreted complex glycosylated recombinant human erythropoietin in the Physcomitrella Δ‐fuc‐t Δ‐xyl‐t mutant , 2007 .
[94] Andrea Barta,et al. The expression of a nopaline synthase — human growth hormone chimaeric gene in transformed tobacco and sunflower callus tissue , 1986, Plant Molecular Biology.
[95] Olawole O. Obembe,et al. India's biotechnology boom: A lesson for Africa , 2009 .
[96] S. Wesselingh,et al. Plant-derived measles virus hemagglutinin protein induces neutralizing antibodies in mice. , 2001, Vaccine.
[97] E. Rybicki. Plant-produced vaccines: promise and reality. , 2009, Drug discovery today.
[98] D. Andersen,et al. Recombinant protein expression for therapeutic applications. , 2002, Current opinion in biotechnology.
[99] P. Beyer,et al. Engineering the provitamin A (beta-carotene) biosynthetic pathway into (carotenoid-free) rice endosperm. , 2000, Science.